CELLS for CELLS treats the first-ever patient with an exosome-produced therapy for osteoarthritis
18 juil. 2022 15h54 HE
|
Cells for Cells
SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- Cells for Cells ("C4C"), a clinical-stage biotech pioneering allogeneic stem cell and stem-cells-derived therapeutics for high-impact chronic...